-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-12-27
Values as of: 2024-12-27
The investment seeks to track the investment results of the Dow Jones U.S. Select Regional Banks Index. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. The underlying fund measures the performance of the regional bank sector of the U.S. equity market and is a subset of the Dow Jones U.S. Bank Index. The fund is non-diversified.
Company Website : www.ishares.com
Currency: USD
Country : USA
Inception Date: 01/05/2006
Primary Benchmark: DJ US Select Regional Banks TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.44%
Management Expense Ratio: 0.42 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| XVIPF | Xvivo Perfusion AB (publ) | 4.06 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| XLF | Financial Select Sector SPDR®.. | 0.13 % |
N/A |
USD 47.66B |
| VFH | Vanguard Financials Index Fund.. | 0.10 % |
N/A |
USD 11.44B |
| FNCL | Fidelity® MSCI Financials Ind.. | 0.08 % |
N/A |
USD 2.06B |
| FXO | First Trust Financials AlphaDE.. | 0.63 % |
N/A |
USD 2.01B |
| BIZD | VanEck BDC Income ETF | 0.41 % |
N/A |
USD 1.35B |
| VPC | Virtus Private Credit ETF | 0.00 % |
N/A |
USD 0.05B |
| BDCZ | UBS AG London Branch ELKS 4 | 0.00 % |
N/A |
USD 0.02B |
| IYF | iShares U.S. Financials ETF | 0.42 % |
N/A |
N/A |
| IYG | iShares U.S. Financial Service.. | 0.42 % |
N/A |
N/A |
| IAI | iShares U.S. Broker-Dealers & .. | 0.42 % |
N/A |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| LDRS | 0.00 % | 0.60 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 20.79% | 29% | F | 79% | B- | ||
| Dividend Return | 2.60% | 71% | C- | 41% | F | ||
| Total Return | 23.39% | 29% | F | 78% | C+ | ||
| Trailing 12 Months | |||||||
| Capital Gain | 20.79% | 29% | F | 79% | B- | ||
| Dividend Return | 2.60% | 71% | C- | 41% | F | ||
| Total Return | 23.39% | 29% | F | 78% | C+ | ||
| Trailing 5 Years | |||||||
| Capital Gain | -0.84% | 24% | F | 47% | F | ||
| Dividend Return | 12.81% | 59% | D- | 41% | F | ||
| Total Return | 11.96% | 6% | D- | 40% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 11.55% | 18% | F | 68% | D+ | ||
| Dividend Return | 14.12% | 12% | F | 69% | C- | ||
| Total Return | 2.57% | 76% | C+ | 58% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 40.26% | 12% | F | 25% | F | ||
| Risk Adjusted Return | 35.08% | 12% | F | 49% | F | ||
| Market Capitalization | 0.47B | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
